Home Page

 
Sleep 2018 Voxmedia Program Image



         Fine-tuning the Management of Narcolepsy
         and Excessive Daytime Sleepiness in
         Obstructive Sleep Apnea

          Monday, June 4, 2018

         Hilton Baltimore
         Holiday Ballroom 2nd Floor
         401 West Pratt Street
         Baltimore, Maryland

         Dinner & Registration: 6:15 pm - 6:45 pm
         Symposium:  6:45 pm - 8:45 pm

Registration for this program is now closed.

 
Faculty:  Michael Thorpy, MD (Chair); Michael Sateia, MD;  Thomas Scammell, MD; Kingman Strohl, MD;  Phyllis Zee, MD, PhD
Program Overview:

This educational initiative will consist of a live program, focusing on the diagnosis and treatment of narcolepsy and EDS in OSA. Format will consist of state-of-the-art lectures and debates.

Educational Objectives: 
Upon completion of this program, attendees should be able to:

  • Identify the challenges associated with diagnosis of EDS in patients with OSA.
  • Describe effective strategies for treatment of EDS in OSA patients.
  • Indicate best practices for diagnosing narcolepsy.
  • Discuss the clinical profiles of current and emerging therapies for treatment of narcolepsy.
  • Target Audience:  This educational activity is intended for physicians and other healthcare professionals involved in the management of sleep disorders.

    Accreditation & Credit Designation Statements:
    Voxmedia LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credit(s) through its reciprocity agreements.

    The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits from organizations accredited by the ACCME.

    Educational Grant: Voxmedia gratefully acknowledges the educational grant provided by Jazz Pharmaceuticals, Inc.

     

    Free CME Here